Drug Trial Radar · NCT02787304
Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)
Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
197
Actual
Start
Oct 24, 2016
Primary completion
Jul 27, 2018
Study completion Jul 27, 2018
Sponsor
- Lead sponsor
- Mirum Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if the investigational treatment volixibat (SHP626) is safe, tolerable and effective in adults with nonalcoholic steatohepatitis (NASH).
Conditions
- Non-Alcoholic Steatohepatitis
Interventions
SHP626Drug
5 mg, 10 mg, and 20 mg of SHP626 capsule by orally once daily in a double-blinded fashion
PlaceboDrug
Matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Achieving Binary Response on Liver Histology Between Volixibat (SHP626) and Placebo at Week 48Time frame: Baseline, Week 48
Locations
65 sites in 4 countries. Site status is shown where the registry gives one.
Southern California Research Center
Coronado, California
Fresno Clinical Research Center
Fresno, California
Ceders-Sinai Medical Center
Los Angeles, California
California Liver Research Institute
Pasadena, California
Inland Empire Liver Foundation
Rialto, California
South Denver Gastroenterology, PC
Englewood, Colorado
Medstar Georgetown University Hospital
Washington D.C., District of Columbia
George Washington (GW) Medical Faculty Associates
Washington D.C., District of Columbia
Schiff Center for Liver Diseases
Miami, Florida
South Florida Center of Gastroenterology
Wellington, Florida
Internal Medicine Associates of Wellstar Atlanta Medical
Atlanta, Georgia
Emory University
Atlanta, Georgia
Gastrointestinal Specialists of Georgia
Marietta, Georgia
The Queen's Medical Center - Liver Center
Honolulu, Hawaii
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Liver Research Center
Louisville, Kentucky
Tulane University Health Sciences Center
New Orleans, Louisiana
Louisiana Research Center, LLC
Shreveport, Louisiana
Mercy Medical Center
Baltimore, Maryland
Digestive Disease Associates
Catonsville, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Massachusetts Medical School
Worcester, Massachusetts
Henry Ford Health System
Novi, Michigan
University of Mississippi Medical Center
Jackson, Mississippi
Kansas City Research Institute
Kansas City, Missouri
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
Northwell Health Inc.
Manhasset, New York
Concorde Medical Group PLLC
New York, New York
University of Rochester Medical Center
Rochester, New York
Center for Liver Disease
Charlotte, North Carolina
DUMC-Gastroenterology
Durham, North Carolina
Cumberland Research Associates, LLC
Fayetteville, North Carolina
Carolinas Center for Liver Disease
Statesville, North Carolina
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Clinsearch, LLC
Chattanooga, Tennessee
University of TN Health Science Center
Memphis, Tennessee
Quality Medical Research
Nashville, Tennessee
Austin Center for Clinical Research
Austin, Texas
Methodist Health Systems Clinical
Dallas, Texas
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.